| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 153 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Total Income - EUR | 153 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Total Expenses - EUR | 472 | 67 | 44 | 43 | 42 | 0 | - | - | - | - |
| Gross Profit/Loss - EUR | -319 | -67 | -44 | -43 | -42 | 0 | - | - | - | - |
| Net Profit/Loss - EUR | -321 | -67 | -44 | -43 | -42 | 0 | - | - | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
Check the financial reports for the company - Genoprocez S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Current Assets | 245 | 242 | 238 | 234 | 229 | 225 | - | - | - | - |
| Inventories | 198 | 196 | 192 | 189 | 185 | 182 | - | - | - | - |
| Receivables | 45 | 45 | 44 | 43 | 42 | 41 | - | - | - | - |
| Cash | 2 | 2 | 2 | 2 | 2 | 2 | - | - | - | - |
| Shareholders Funds | -276 | -340 | -378 | -414 | -448 | -439 | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | - | - | - | - |
| Debts | 521 | 582 | 616 | 648 | 677 | 664 | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4771 - 4771" | |||||||||
| CAEN Financial Year |
4771
|
|||||||||
Comments - Genoprocez S.r.l.